Evaxion A/S: Financial statements 2013
CVR: 31762863
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Evaxion A/S (CVR 31762863) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 518,400 and a net result of DKK 419,463 compared with DKK 324,467 the year before. Equity in the 2013 report amounted to DKK 538,784. The solvency ratio was 55.1%.
- Gross Profit
- DKK 518,400
- Profit/Loss
- DKK 419,463
- Equity
- DKK 538,784
- Total Assets
- DKK 978,389
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 518 t. | 419 t. | 539 t. | - |
| 2012 | 1.4 mio. | - | 324 t. | 119 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Evaxion A/S has published its annual report for 2012. Revenue came to DKK 1,374,684, and the net result was DKK 324,467.
About Evaxion A/S
Evaxion A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named EVAXION BIOTECH A/S and EVAXION BIOTECH ApS. The management consists of Helen Katrina Tayton-Martin, Andreas Holm Mattsson and Thomas Frederik Schmidt. The board consists of Marianne Søgaard (chair), Jens Bitsch-Nørhave, Lars Holtug and Lars Aage Staal Wegner. The company is owned by BNY (Nominees) Limited (as nominee of The Bank of New York Mellon). The company has 44 employees (2026). In 2025, the company reported revenue of DKK 48,112,000 and a net result of DKK -51,489,000 compared with DKK -73,277,000 the year before. Equity in the 2025 report amounted to DKK 108,250,000.